A tragic event has sparked a crucial conversation about patient safety and healthcare governance in Nigeria. The recent death of Nkanu, Chimamanda Ngozi Adichie's young son, has sent shockwaves through the medical community, prompting urgent calls for action.
The Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN) has sounded the alarm, describing the incident as a devastating failure that demands immediate attention and accountability.
But here's where it gets controversial...
Emerging details suggest a serious breach of internationally recognized standards in pediatric anesthesia and medication safety. The use of propofol, a sedative, in a child under three years old has raised red flags, as it directly contradicts established global guidelines.
Pharm. Elechi Oyim, AHAPN's National Chairman, emphasizes that this practice poses significant risks. Propofol Infusion Syndrome (PRIS), a complication associated with high mortality rates, is a serious concern when administering propofol to young children for extended periods.
"PRIS can lead to severe metabolic acidosis, muscle breakdown, and cardiac failure," Oyim warns. "Global health authorities, including the WHO and FDA, have repeatedly cautioned against such use in pediatric intensive care."
The FDA's stance is clear: propofol is not approved for long-term sedation in pediatric intensive care units due to the high risk of fatalities associated with PRIS.
Beyond the clinical implications, AHAPN highlights a deeper issue: a systemic failure in Nigeria's healthcare governance.
And this is the part most people miss...
The absence of proper safeguards and the exclusion of pharmacists from critical care decisions create a dangerous environment. Oyim argues that clinical judgment, without independent review, becomes an institutional risk.
"Healthcare delivery, like justice, relies on checks and balances. Pharmacists, trained to detect unsafe drug choices and monitor dosages, should be integral to the decision-making process, especially in anesthesia and pediatric care."
AHAPN calls for a thorough investigation into Nkanu's death and urgent reforms to strengthen multidisciplinary medication governance in Nigerian hospitals.
"Paediatric patients deserve the highest level of protection. Exposing them to avoidable pharmacological risks is a breach of ethical standards."
Oyim concludes with a powerful message: "Healthcare must evolve towards collaborative accountability. The current system not only fails clinically but also ethically and morally."
As we reflect on this tragic loss, it's crucial to consider the broader implications for patient safety and healthcare governance. What are your thoughts on this matter? Is it time for a paradigm shift in healthcare delivery?
